Research - New York, New York, United States
Artemis Therapeutics, Inc. (ATMS) is a biopharmaceutical company developing novel treatments for serious and life-threatening infections. The company's lead drug candidate, Artemisone, is a best-in-class artemisinin which has been studied in a phase 2 clinical trial for the treatment of malaria (p. falciparum) and is currently undergoing in vitro evaluation for its activity against human cytomegalovirus (CMV), including transplant CMV and congenital CMV.
Outlook
WordPress.org
Google Font API
YouTube
Mobile Friendly